Dr Lal PathLabs’ arm gets nod for signing binding term sheet

| Updated on October 01, 2019 Published on October 01, 2019

The board of Dr Lal PathLabs’ wholly-owned subsidiary Pathlabs Unifiers Private Limited, on Tuesday approved signing a binding term sheet for acquisition of 70 per cent equity stake in a new company to be incorporated.

According to the term sheet, the new company will house the business of Amins Pathology Referral Laboratory, a proprietorship concern of Dr Ripal Padmani, and engaged in the pathology business in Vadodara, Gujarat, before Pathlabs Unifiers Private Limited buys 70 per cent stake in it. Shares of Dr Lal PathLabs edged down 1.52 per cent at ₹1,367.20 on the BSE.

Published on October 01, 2019
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.